Hedge Fund - DAFNA Capital Management
Biohaven Pharmaceutical Holding Co Ltd. (BHVN)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2022 - Q4 (2022-12-31) | $0 | 0% | 0 | $14.12 |
| 2 | 2022 - Q3 (2022-09-30) | $16,644,000 | 4.47% | 110,100 | $7.42 |
| 3 | 2022 - Q2 (2022-06-30) | $16,043,000 | 4.37% | 110,100 | $127.74 |
| 4 | 2022 - Q1 (2022-03-31) | $9,201,000 | 2.39% | 77,600 | $124.72 |
| 5 | 2021 - Q4 (2021-12-31) | $8,007,000 | 2.01% | 58,100 | $127.16 |
| 6 | 2021 - Q3 (2021-09-30) | $12,238,000 | 3.24% | 88,100 | $124.86 |
| 7 | 2021 - Q2 (2021-06-30) | $9,135,000 | 1.91% | 94,100 | $81.16 |
| 8 | 2021 - Q1 (2021-03-31) | $6,398,000 | 1.51% | 93,600 | $80.88 |
| 9 | 2020 - Q4 (2020-12-31) | $7,037,000 | 2.09% | 82,100 | $84.74 |
| 10 | 2020 - Q3 (2020-09-30) | $5,500,000 | 1.78% | 84,600 | $65.54 |
| 11 | 2020 - Q2 (2020-06-30) | $6,404,000 | 1.84% | 87,600 | $53.22 |
| 12 | 2020 - Q1 (2020-03-31) | $3,083,000 | 1.28% | 90,600 | $45.72 |
| 13 | 2019 - Q4 (2019-12-31) | $4,067,000 | 1.39% | 74,700 | $49.52 |
| 14 | 2019 - Q3 (2019-09-30) | $3,963,000 | 1.49% | 95,000 | $42.25 |
| 15 | 2019 - Q2 (2019-06-30) | $4,160,000 | 1.56% | 95,000 | $56.37 |
| 16 | 2019 - Q1 (2019-03-31) | $4,118,000 | 1.77% | 80,000 | $43.20 |
| 17 | 2018 - Q4 (2018-12-31) | $2,958,000 | 1.47% | 80,000 | $36.05 |
| 18 | 2018 - Q3 (2018-09-30) | $1,127,000 | 0.46% | 30,000 | $36.78 |
| 19 | 2018 - Q2 (2018-06-30) | $929,000 | 0.43% | 23,500 | $31.73 |
The displayed share prices are average quarterly stock market prices.